glp-1 news nov 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 drugs can be ‘too

They are different treatments with different risk profiles

Others say their digestion issues have continued even after they stopped taking the drugs

The information obtained by using these technologies (including, but not limited to, the pages you visit on our website, which web address you came from, information about the devices and software you use, and the content you view) helps us in various ways, including, but not limited to, to customize your experience, improve the Services, learn what areas of the Services are of most interest to our customers, and troubleshoot any issues

Int J Mol Med 2017;39:102936.ArticlePubMed 57

GLP-1 Medications Approved for Different Uses Not all GLP-1 drugs are FDA-approved for the same thing, and this is important when it comes to insurance coverage